Positive outcomes in clinical evaluation of bioengineered cornea

Symptomatic improvement after two years of follow-up

Positive outcomes in clinical evaluation of bioengineered cornea
Cheryl Guttman Krader
Cheryl Guttman Krader
Published: Thursday, May 2, 2019
Findings from a Phase I study suggest that a fibrin-agarose-based anterior lamellar corneal substitute is safe as a treatment for severe trophic corneal ulcers or its sequelae, reported Miguel Gonzalez-Andrades, MD, at the annual meeting of the Association for Vision and Research in Vancouver, Canada. Clinical evaluation of the corneal substitute has now advanced into a randomised Phase IIA study including amniotic membrane transplantation as a control arm. The Phase I study enrolled five patients who had severe corneal ulcers refractory to conventional treatment or sequelae of previous ulcers. During the 24-month follow-up, there were no serious treatment-related adverse events. Improvements in the severity of superficial punctate keratopathy, corneal epithelial defect, corneal neovascularisation, keratinization, and conjunctival hyperemia, were seen in some or all patients. Subjectively, all patients reported symptomatic improvement and said they would repeat the procedure. “Only two patients had improvement in visual acuity, but these were very severe cases and hopefully we can better evaluate efficacy in the next study phase,” said Dr Gonzalez-Andrades, University of Granada, Granada, Spain.  
Tags: ARVO 2019, corneal substitute
Latest Articles
Addressing Postoperative Visual Complications

Managing aberrations after laser refractive surgery requires a multi-layered approach.

Read more...

3D Printing Helps Transform Ukrainian Eye Care

The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.

Read more...

Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation

Read more...

Emerging Microbial Trends That Could Affect Your Practices

A triptych of challenges paints a concerning picture for ophthalmologists across the globe.

Read more...

Improving Outcomes with Laser-Assisted Surgery

Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.

Read more...

Could the Corneal Transplant Pool Increase?

Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.

Read more...

Matching Premium IOLs to Visual Lifestyles

From monofocal to full-range solutions, each practice needs comprehensive understanding.

Read more...

Going Dutch on Acanthamoeba Keratitis

A world-first trial suggests a new medication could beat the disease.

Read more...

Avoiding Intracorneal Ring Segment Complications

Femtosecond lasers are helping improve refractive results with fewer problems.

Read more...

Fine-Tuning IOLs After Surgery

Lens power adjustment technology is developing quickly.

Read more...